Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Healthcare (Basel) ; 12(3)2024 Jan 26.
Article in English | MEDLINE | ID: mdl-38338206

ABSTRACT

Promoting subjective well-being is a crucial challenge in aging societies. In 2022, we launched a community-based intervention trial (the Chofu-Digital-Choju Movement). This initiative centered on fostering in-person and online social connections to enhance the subjective well-being of older adults. This paper describes the study design and baseline survey. This quasi-experimental study involved community-dwelling older adults aged 65-84 years in Chofu City, Tokyo, Japan. A self-administered questionnaire was distributed to 3742 residents (1681 men and 2061 women), and a baseline survey was conducted in January 2022. We assessed subjective well-being (primary outcome); psychosocial, physical, and dietary factors; and the use of information and communication technology variables (secondary outcomes) among the participants. After the intervention involving online classes, community hubs, and community events, a 2-year follow-up survey will be conducted to evaluate the effects of the intervention, comparing the intervention group (participants) with the control group (non-participants). We received 2503 questionnaires (66.9% response rate); of these, the analysis included 2343 questionnaires (62.6% valid response rate; mean age, 74.4 (standard deviation, 5.4) years; 43.7% male). The mean subjective well-being score was 7.2 (standard deviation, 1.9). This study will contribute to the development of a prototype subjective well-being strategy for older adults.

2.
J Vet Med Sci ; 70(8): 849-52, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18772564

ABSTRACT

The concentration of fecal secretory immunoglobulin A (sIgA) in neonate and weaning piglets was measured daily from 1 day after birth to 50 days of age. The concentration of fecal sIgA started from the level of 10(4) microg/g wet feces 1 day after birth and then increased to a maximal value of up to 10(5) microg/g within a few days of birth. The values constantly declined to between 10(1) and 10(2) microg/g for the next 10 days and were relatively constant until weaning. The level of sIgA in the feces remained very low until at least 50 days of age. The vulnerability of pre- or post-weaning piglets can be explained, at least in part, by this low level of sIgA in the intestine.


Subject(s)
Animals, Newborn/immunology , Feces/chemistry , Immunoglobulin A/metabolism , Swine/immunology , Aging/drug effects , Aging/immunology , Animals , Anti-Bacterial Agents/pharmacology , Female , Pregnancy , Swine/growth & development , Weaning
3.
Biosci Biotechnol Biochem ; 70(3): 606-14, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16556975

ABSTRACT

Butyrate induces apoptosis of various cancer cell lines in a p53-independent manner and inhibits the proliferation of cancer cells. In a previous report, we reported a significant reduction in tumor incidence in rat colon as a result of dietary sodium gluconate (GNA). The stimulation of apoptosis through enhanced butyrate production in the large intestine was involved in the antitumorigenic effect of GNA. In the present study, a cDNA microarray analysis was performed to investigate the particular mechanism involved in the antitumorigenic effect of GNA. Some up-regulated genes suggested by microarray analysis were further evaluated using real-time PCR. A microarray revealed that GNA regulates the expression of retinoic acid receptor (RAR) and retinoid X receptor (RXR), and several genes known as the target of retinoids in cancer cells. In other words, the antitumorigenic effect of GNA may involve the regulation of the retinoid signaling pathway by butyrate in a retinoid-independent manner.


Subject(s)
Colon/drug effects , Colon/metabolism , Colorectal Neoplasms/genetics , Disease Models, Animal , Gene Expression Regulation, Neoplastic/drug effects , Gluconates/pharmacology , Animals , Body Weight/drug effects , Colon/pathology , Colorectal Neoplasms/prevention & control , Eating , Gene Expression Regulation, Neoplastic/genetics , Male , Oligonucleotide Array Sequence Analysis , Proto-Oncogene Proteins c-bcl-2/genetics , RNA, Messenger/genetics , Rats , Receptors, Retinoic Acid/genetics , Retinoic Acid Receptor alpha , Retinoid X Receptor gamma/genetics
4.
J Nutr ; 134(4): 940-4, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15051851

ABSTRACT

Butyrate has an antitumorigenic effect on colorectal cancer cell lines. Dietary sodium gluconate (GNA) promotes butyrate production in the large intestine. Accordingly, we examined the effect of dietary GNA on tumorigenesis in the large intestine in rats. Male Fisher-344 rats (n = 32) were divided into 4 groups: 2 diets (with or without 50 g GNA/kg basal diet) x 2 treatments (with or without carcinogen administration). Colonic tumors were induced by 3 intraperitoneal injections of azoxymethane (15 mg/kg body wt, 1 time/wk) and dietary deoxycholic acid (2 g/kg basal diet). The experiment was conducted for 33 wk except for a few rats. Ingestion of GNA increased cecal butyrate concentration at the end of experiment (P < 0.01). No tumor development occurred in the untreated groups. Ingestion of GNA decreased the incidence of tumors in rats administered the carcinogen (37.5 vs. 100%, P < 0.05). Ingestion of GNA also decreased the mean number of tumors per rat (0.5 +/- 0.8 vs. 2.8 +/- 1.5, P < 0.01). beta-Catenin accumulation and TdT-mediated dUTP nick end labeling (TUNEL) positive cells in tumors were histochemically examined. The results of this study suggested that the antitumorigenic effect of GNA may involve the stimulation of apoptosis through enhanced butyrate production in the large intestine.


Subject(s)
Butyrates/metabolism , Colorectal Neoplasms/prevention & control , Diet , Gluconates/administration & dosage , Adenocarcinoma/chemically induced , Adenocarcinoma/pathology , Adenocarcinoma/prevention & control , Adenoma/chemically induced , Adenoma/pathology , Adenoma/prevention & control , Animals , Apoptosis/drug effects , Azoxymethane/administration & dosage , Carcinogens/administration & dosage , Cecum/chemistry , Cecum/pathology , Colon/chemistry , Colon/pathology , Colorectal Neoplasms/chemically induced , Colorectal Neoplasms/pathology , Cytoskeletal Proteins/analysis , Deoxycholic Acid/administration & dosage , Immunohistochemistry , In Situ Nick-End Labeling , Intestines/pathology , Male , Organ Size , Rats , Rats, Inbred F344 , Trans-Activators/analysis , beta Catenin
SELECTION OF CITATIONS
SEARCH DETAIL
...